Share:
Peer-Reviewed Publication
Clin Transl Sci2023;16(2):326-337.February 1, 2023Journal Article

Antidepressant drug-drug-drug interactions associated with unintentional traumatic injury: Screening for signals in real-world data.

Cheng Chen1,2, Sean Hennessy1,2,3,4, Colleen M Brensinger1,2, Warren B Bilker1,5, Sascha Dublin6,7, Sophie P Chung8, John R Horn9, Kacie F Bogar1,2, Charles E Leonard1,2,3
1Center for Real-World Effectiveness and Safety of Therapeutics, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
2Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
3Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
4Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
5Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
6Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
7Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington, USA.
8Epocrates Medical Information, AthenaHealth, Inc., Watertown, Massachusetts, USA.
9Department of Pharmacy, School of Pharmacy, University of Washington, Seattle, Washington, USA.

Abstract

Antidepressants are associated with traumatic injury and are widely used with other medications. It remains unknown how drug-drug-drug interactions (3DIs) between antidepressants and two other drugs may impact potential injury risks associated with antidepressants. We aimed to generate hypotheses regarding antidepressant 3DI signals associated with elevated injury rates. Using 2000-2020 Optum's de…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.